International Clinical Trial: Can Chinese herbal medicine help prevent relapse after ixekizumab treatment in adults with moderate-to-severe plaque psoriasis?

Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ISRCTN91905052) titled 'Can Chinese herbal medicine help prevent relapse after ixekizumab treatment in adults with moderate-to-severe plaque psoriasis?' on May 1.

Study Type: Interventional

Study Design: Allocation: Randomized controlled trial Masking: Blinded (masking used) Control: Placebo Assignment: Sequential Purpose: Treatment

Primary Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine

Condition: Moderate-to-severe plaque psoriasis Skin and Connective Tissue Diseases

Intervention: This is a multicentre sequential interventional study with two stages.

Stage 1 (induction stage): up to 200 eligible adults with...